Alpha/Beta Arteether is an Active Pharmaceutical Ingredient (API) belonging to the artemisinin class of antimalarial drugs. It is a semisynthetic derivative of artemisinin and is used in the manufacture of injectable formulations for the treatment of malaria, especially infections caused by Plasmodium falciparum, including chloroquine-resistant malaria. It acts rapidly by generating free radicals inside the malaria parasite, leading to parasite death. Alpha/Beta Arteether is administered by intramuscular injection and is intended for treatment rather than prevention of malaria. It is grouped under the following drug class(es): Terpenes. Its therapeutic use is listed as antimalarials. The directory classifies it as a commercial API with a semi-synthetic source/manufacturing origin. Other names for this substance include 3, 12-Epoxy-12H-pyrano(4, 3-j)-1, 2-benzodioxepin, 10-ethoxydecahydro-3, 6, 9-trimethyl-, (3R-(3-alpha, 5a-beta, 6-beta, 8a-beta, 9-alpha, 10-alpha, 12-beta, 12aR*))-, mixt. with (3R-(3-alpha, 5a-beta, 6-beta, 8a-beta, 9-alpha, 10-beta, 12-beta, 12aR*))-10-ethoxydecahydro-3, 6, 9-trimethyl-3, 12-epoxy-12H-pyrano(4, 3-j)-1 and 2-benzodioxepin. Its PubChem CID is 3037930.
Alpha Beta Arteether
| CAS No | 123492-25-1 |
|---|---|
| Molecular Formula | C34H56O10 |
| Molecular Weight | 624.80 g/mol |
| Synonyms | (1S,4S,5R,8S,9R,10R,12R)-10-ethoxy-1,5,9-trimethyl-11,14,15,16-tetraoxatetracyclo[10.3.1.04,13.08,13]hexadecane;(1S,4S,5R,8S,9R,10S,12R)-10-ethoxy-1,5,9-trimethyl-11,14,15,16-tetraoxatetracyclo[10.3.1.04,13.08,13]hexadecane |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Alpha/Beta Arteether is an Active Pharmaceutical Ingredient (API) belonging to the artemisinin class of antimalarial drugs.
The listed CAS number is 123492-25-1.
The listed molecular formula is C34H56O10.
The listed molecular weight is 624.80 g/mol.
(1S,4S,5R,8S,9R,10R,12R)-10-ethoxy-1,5,9-trimethyl-11,14,15,16-tetraoxatetracyclo[10.3.1.04,13.08,13]hexadecane;(1S,4S,5R,8S,9R,10S,12R)-10-ethoxy-1,5,9-trimethyl-11,14,15,16-tetraoxatetracyclo[10.3.1.04,13.08,13]hexadecane.
The source lists 3, 12-Epoxy-12H-pyrano(4, 3-j)-1, 2-benzodioxepin, 10-ethoxydecahydro-3, 6, 9-trimethyl-, (3R-(3-alpha, 5a-beta, 6-beta, 8a-beta, 9-alpha, 10-alpha, 12-beta, 12aR*))-, mixt. with (3R-(3-alpha, 5a-beta, 6-beta, 8a-beta, 9-alpha, 10-beta, 12-beta, 12aR*))-10-ethoxydecahydro-3, 6, 9-trimethyl-3, 12-epoxy-12H-pyrano(4, 3-j)-1 and 2-benzodioxepin.